Michael D. Stifelman
Also known as Michael Stifelman
Michael Stifelman is a urologist whose research connects robotic surgery with machine-learning analysis of surgical performance. He earned his medical degree at Albert Einstein College of Medicine, trained in urology at Columbia Presbyterian, and completed an endourology and laparoscopy fellowship at Weill Cornell. His 2009 study compared robot-assisted with laparoscopic partial nephrectomy at three academic centers. At Hackensack, he directed robotic surgery as the hospital reached 1,000 single-port procedures in 2023; the department adopted the da Vinci 5 and evaluated an AI prostate-cancer test in 2024, and its team used machine learning to study surgical video in 2025. As of October 2026, he is Chair of Urology and Director of Robotic Surgery at Hackensack University Medical Center and Professor and Founding Chair of Urology at Hackensack Meridian School of Medicine.
Timeline
-
1999–2000
Medical and surgical training
He earns his medical degree at Albert Einstein College of Medicine and completes urology residency at New York Presbyterian/Columbia University in 1999. He completes a fellowship at New York-Presbyterian Hospital in 2000, with endourology and laparoscopy training at Weill Cornell Medical Center.
-
2009
Comparing kidney surgery
In 2009, he coauthors a multi-institutional comparison of robotic and laparoscopic partial nephrectomy for kidney tumors. The study examines operations at three academic centers from 2004 to 2008 and reports lower blood loss and shorter hospital stays in the robotic group.
-
2016
Joining Hackensack
In 2016, he joins HackensackUMC after serving at NYU Langone as professor of urology at NYU School of Medicine, director of its Robotic Surgery Center, and chief of Urology Services at Tisch Hospital.
-
2018–March 2023
1,000 single-port procedures
Hackensack University Medical Center gains access to the da Vinci single-port system in 2018 and performs its 1,000th single-port robotic procedure in March 2023. Stifelman directs robotic surgery for Hackensack Meridian Health Network.
-
2024
Adopting the da Vinci 5
Hackensack's Department of Urology adopts the da Vinci 5 in 2024. The platform lets surgeons quantify and segment procedures.
-
October 2024
Evaluating ArteraAI
In October 2024, Hackensack urology researchers receive a grant to evaluate ArteraAI's estimate of prostate-cancer aggressiveness after surgery. The test combines biopsy-slide images with clinical data, and Stifelman says Hackensack is the first center in the country to evaluate the AI technology.
-
December 2025
Machine learning in surgery
In December 2025, Hackensack's Urology team uses machine learning to analyze surgical-video steps alongside hundreds of operative performance indicators. Its analysis identifies steps and instrument measures linked to erectile-function preservation, and residents and fellows receive objective training feedback.
-
As of October 2026
Chair and robotic surgery director
As of October 2026, he serves as Chair of Urology and Director of Robotic Surgery at Hackensack University Medical Center, and as Professor and Founding Chair of Urology at Hackensack Meridian School of Medicine.
Career
- Since 2021Hackensack Meridian School of MedicineProfessor and Chair of Urology
- Since 2016Hackensack University Medical CenterChair of Urology and Director of Robotic Surgery
- Until 2016New York University School of MedicineDirector
- 2001–2016NYU Langone HealthProfessor of Urology; Director of the Robotic Surgery Center; Chief of Urology Services at Tisch Hospital
- 2001–2016New York UniversityProfessor of Urology
- 1997–1999Columbia University
- Hackensack Meridian Health NetworkDirector of Robotic Surgery
Education
- 2000New York-Presbyterian HospitalFellowship
- 1999New York-Presbyterian HospitalUrology residency
- Albert Einstein College of MedicineMedical degree
- Weill Cornell MedicineEndourology and laparoscopy fellowship
Most-cited works
- Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy for Renal Tumors: A Multi-Institutional Analysis of Perioperative Outcomes
- A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging–Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial
- Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy
- Trifecta and optimal perioperative outcomes of robotic and laparoscopic partial nephrectomy in surgical treatment of small renal masses: a multi‐institutional study
- Robot Assisted Laparoscopic Partial Nephrectomy: Initial Experience
Sources and credits
Photo: We have no published photo of Michael D. Stifelman yet. Send us a free-licensed photo.
- Michael D Stifelman, MD Reconstructive Urology, Urologic Oncology in Hackensack, NJ
- Michael Stifelman
- Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes.
- Hackensack Meridian Hackensack University Medical Center Performs 1,000th Single-Port Robotic Procedure - More Than Any Other Hospital in the Country
- Harnessing the Power of AI for Better Urological Surgery Outcomes
- John Theurer Cancer Center First in the Country to Evaluate New AI Technology Assessing Aggressiveness of Prostate Cancer Post Surgery
- From Robotics to Reconstruction: Hackensack Urology to Unveil Diverse, Cutting-Edge Research at AUA 2026




